Dr. Zorsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Eaton Place
Worcester, MA 01608Phone+1 806-341-2110- Is this information wrong?
Summary
- Dr. Paul Zorsky is a hematologist in Worcester MA. He received his medical degree from the University of Connecticut and has been in practice for 44 years. He specializes in hematologic oncology and is experienced in hematology and medical oncology. Furthermore, he has more than 10 publications and over 100 citings.
Education & Training
- George Washington UniversityFellowship, Hematology and Medical Oncology, 1985 - 1987
- George Washington UniversityResidency, Internal Medicine, 1982 - 1984
- George Washington UniversityInternship, Internal Medicine, 1978 - 1979
- Uconn School Of MedicineClass of 1978
Certifications & Licensure
- MA State Medical License 2023 - 2026
- ME State Medical License 2021 - 2025
- TX State Medical License 1995 - 2025
- MD State Medical License 2009 - 2023
- DE State Medical License 2009 - 2017
- OK State Medical License 1981 - 2010
- FL State Medical License 1991 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- Join now to see all
Publications & Presentations
PubMed
- 91 citationsDenosumab for treatment of hypercalcemia of malignancy.Mimi I. Hu, Ilya G. Glezerman, Sophie Leboulleux, Karl L. Insogna, Rasim Gucalp, Waldemar Misiorowski, Bennett Yu, Paul Zorsky, Diego Tosi, Alberto Bessudo, Arnaud Jac...> ;The Journal of Clinical Endocrinology and Metabolism. 2014 Jun 10
- 4 citationsNumber of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II study.Stephen E. Wright, Kathleen Rewers-Felkins, Imelda S. Quinlin, Catherine A. Phillips, Mary Townsend, Ramila Philip, Paul Zorsky, Panpit Klug, Lijun Dai, Mohammad Hussa...> ;Immunological Investigations. 2010 Jul 23
- 13 citationsTumor Burden Influences Cytotoxic T Cell Development in Metastatic Breast Cancer Patients—A Phase I/II StudyStephen E. Wright, Kathleen Rewers-Felkins, Imelda S. Quinlin, Catherine A. Phillips, Mary Townsend, Ramila Philip, Paul Zorsky, Panpit Klug, Lijun Dai, Mohammad Hussa...> ;Immunological Investigations. 2009 Oct 28
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: